1. Home
  2. OPAL vs IMUX Comparison

OPAL vs IMUX Comparison

Compare OPAL & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPAL Fuels Inc.

OPAL

OPAL Fuels Inc.

HOLD

Current Price

$2.10

Market Cap

65.8M

Sector

Utilities

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

HOLD

Current Price

$1.19

Market Cap

75.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPAL
IMUX
Founded
1998
2016
Country
United States
United States
Employees
N/A
66
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.8M
75.2M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
OPAL
IMUX
Price
$2.10
$1.19
Analyst Decision
Sell
Strong Buy
Analyst Count
4
5
Target Price
$2.81
$4.25
AVG Volume (30 Days)
162.6K
4.7M
Earning Date
01-01-0001
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.00
EPS
0.07
N/A
Revenue
$299,972,000.00
N/A
Revenue This Year
$17.25
N/A
Revenue Next Year
$17.23
N/A
P/E Ratio
$29.29
N/A
Revenue Growth
17.13
N/A
52 Week Low
$1.26
$0.51
52 Week High
$4.08
$1.51

Technical Indicators

Market Signals
Indicator
OPAL
IMUX
Relative Strength Index (RSI) 45.89 58.29
Support Level $2.03 $0.64
Resistance Level $2.49 N/A
Average True Range (ATR) 0.12 0.12
MACD 0.01 0.02
Stochastic Oscillator 43.70 51.49

Price Performance

Historical Comparison
OPAL
IMUX

About OPAL OPAL Fuels Inc.

OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: